Reagen Loughran
Primary Care · London, KYNPI 1821277518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $29.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Amgen$426
- Teva Pharmaceuticals USA, Inc.$353
- Neurocrine Biosciences, Inc.$300
- Phathom Pharmaceuticals, Inc.$234
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,74899%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $1,379 |
| AstraZeneca | 25 | $1,146 |
| Amgen | 23 | $426 |
| Teva Pharmaceuticals USA, Inc. | 13 | $353 |
| Neurocrine Biosciences, Inc. | 5 | $300 |
| Phathom Pharmaceuticals, Inc. | 5 | $234 |
| Axsome Therapeutics, Inc. | 7 | $197 |
| Corcept Therapeutics | 4 | $181 |
| Indivior Inc. | 8 | $150 |
| Bayer | 2 | $145 |
| Amarin Pharma, Inc. | 9 | $135 |
| Biohaven Pharmaceuticals, Inc. | 1 | $117 |
| Lilly USA, LLC | 6 | $115 |
| Pfizer | 6 | $98 |
| Neurelis, Inc. | 1 | $95 |
| Pear Therapeutics (US), Inc. | 3 | $92 |
| Johnson & Johnson | 1 | $53 |
| Gilead | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $47 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Novartis | 2 | $40 |
| Braeburn Inc. | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Mylan Specialty L.p. | 2 | $34 |
| Abbott | 2 | $33 |
| GSK | 2 | $32 |
| Radius Health, Inc. | 1 | $31 |
| Novo Nordisk | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Genentech USA, Inc. | 2 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,790 in reported general payments places this provider in the 90th percentile of 80 primary care providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 281 | $296,206 |
| IngrezzaValbenazine Tosylate | 12 | $100,133 |
| OzempicSemaglutide | 90 | $86,986 |
| FarxigaDapagliflozin Propanediol | 113 | $68,452 |
| EliquisApixaban | 90 | $61,610 |
| Aimovig AutoinjectorErenumab-Aooe | 53 | $50,683 |
| VascepaIcosapent Ethyl | 115 | $43,165 |
| ProliaDenosumab | 15 | $26,871 |
| JanuviaSitagliptin Phosphate | 41 | $25,995 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $21,415 |
| RybelsusSemaglutide | 19 | $19,242 |
| Bydureon BciseExenatide Microspheres | 23 | $19,188 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $17,116 |
| MyrbetriqMirabegron | 33 | $17,083 |
| Rosuvastatin Calcium | 614 | $15,393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $115 | $296,206281 claims |
| Novo NordiskOzempic, Rybelsus | $30 | $106,228109 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $300 | $100,13312 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,146 | $89,867147 claims |
| PfizerEliquis | $98 | $61,61090 claims |
| AmgenProlia | $426 | $26,87115 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $17,08333 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine | $42 | $16,986353 claims |
| AbbVieLinzess | $1,379 | $14,00422 claims |
| NovartisEntresto | $40 | $11,16519 claims |
| Johnson & JohnsonXarelto | $53 | $6,47811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 80 primary care providers in Kentucky.
Other primary care in London
- Royale BrownLondon$252
- Jessica GoettlLouisville$59K
- Angela ClarkBowling Green$10K
- Tara CoyleShelbyville$7K
- Heather AdamsLexington$7K
- Bridget McKinleyElizabethtown$6K
- Tracy DarlingtonCrestview Hills$6K
- Jeryl PittmanRichmond$6K
- Samantha FraleyPrestonsburg$3K
- Pamela PhelpsMorgantown$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.